NEW YORK, Sept. 23, 2021
/PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") – a
leading investment bank, wealth manager, and a subsidiary of
Oppenheimer Holdings (NYSE: OPY) – today announced that it has
successfully concluded its Fall Healthcare Life Sciences &
MedTech Summit. The event, held virtually from September 20 – 23, brought together over 151
leading public and private companies from across the life sciences
and medical technology sectors to discuss key trends and
opportunities with investors.
Michael Margolis, R.Ph.,
Oppenheimer's Co-Head of Healthcare Investment Banking and Head of
Healthcare Life Sciences Investment Banking, said, "The past year
has been an active time for life sciences and med tech companies
seeking to raise capital, develop new and innovative solutions and
accelerate their time-to-market. We were very pleased to offer
companies and investors the opportunity to connect at our
Healthcare Life Sciences & MedTech Summit and to help the
industry move forward."
Thursday, September 23 was the
Summit's Private Company Day, focusing on a select group of private
companies in the emerging biotechnology and life science sectors.
Additionally, Oppenheimer's healthcare life science and med tech
equity research analysts facilitated discussions and questions for
the companies. Analysts in attendance included:
- Matt Biegler, MA – Biotechnology
- Mark Breidenbach, Ph.D. –
Biotechnology
- Francois Brisebois, M.Sc. –
Biotechnology
- Kevin DeGeeter – Biotechnology
and Diagnostics
- Leland Gershell, MD, Ph.D. –
Biopharmaceuticals
- Jeff Jones, Ph.D. –
Biotechnology
- Suraj Kalia, MBA, CFA – Medical
Technology and Devices
- Justin Kim, MBA, MSF –
Biotechnology
- Steven M. Lichtman, MBA –
Medical Devices
- Jay Olson, MBA, CFA –
Biotechnology
- Hartaj Singh, MBA – Biotechnology
- Michael Wiederhorn, MA – Healthcare Providers
Erica L. Moffett, Managing
Director and Associate Director of Research at Oppenheimer, said,
"The last 18 months have clearly reinforced the centrality of the
life sciences and med tech industries across all aspects of our
society and our economy. We are pleased to be able to offer another
successful virtual conference, along with the opportunity for our
clients to meet with management teams to discuss, in detail, key
therapeutic programs in development as well as crucial trends
unfolding in these industries and recent corporate updates."
Oppenheimer & Co. Inc.
Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary
of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange),
and its affiliates provide a full range of wealth management,
securities brokerage and investment banking services to
high-net-worth individuals, families, corporate executives, local
governments, businesses and institutions. For more information,
please visit www.oppenheimer.com.
Media Contact:
Joseph
Kuo / Michael Dugan
Haven Tower Group LLC
424 317 4851 or 424 317 4852
jkuo@haventower.com or mdugan@haventower.com
View original
content:https://www.prnewswire.com/news-releases/oppenheimer--co-inc-announces-successful-conclusion-of-virtual-2021-fall-healthcare-life-sciences-and-medtech-summit-301383849.html
SOURCE Oppenheimer & Co. Inc.